Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 48.09 M43.61 M31.66 M34.12 M28.78 M 138.17 M Research & development 88.94 M79.23 M98.27 M75.88 M95.47 M 348.86 M Operating income 515.51 M101.07 M-178.02 M14.23 M-15.43 M -78.15 M Non-Operating Income, Total 18.16 M18.9 M16.38 M16.7 M18.93 M 70.9 M Interest expense, net of interest capitalized 5.72 M5.52 M5.48 M5.82 M4.9 M 21.73 M Non-Operating Income, excl. Interest Expenses 2.38 M1.48 M1.72 M1.38 M2.2 M 6.78 M Unusual income/expense 10.06 M11.9 M9.18 M9.5 M11.82 M 42.4 M Pretax income 519.85 M107.45 M-203.04 M17.9 M-8.51 M -86.19 M Equity in earnings ————— — Taxes 1.2 M946 K-657 K376 K985 K 1.65 M Non-controlling/minority interest ————— — After tax other income/expense -16.55 M11.87 M229 K-1.3 M8.97 M 19.77 M Net income before discontinued operations 518.65 M106.51 M-202.38 M17.53 M-9.49 M -87.83 M Discontinued operations ————— — Net income 518.65 M106.51 M-202.38 M17.53 M-9.49 M -87.83 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 521.28 M109.14 M-202.38 M17.7 M-9.49 M -85.03 M Basic earnings per share (Basic EPS) 3.220.66-1.250.09-0.06 -0.56 Diluted earnings per share (Diluted EPS) 2.930.62-1.250.28-0.06 -0.41 Average basic shares outstanding 161.05 M162.02 M162.35 M161.99 M163.28 M — Diluted shares outstanding 177.63 M177.22 M162.35 M173.1 M163.28 M — EBITDA 515.96 M101.51 M-177.62 M14.6 M— — EBIT 515.51 M101.07 M-178.02 M14.23 M-15.43 M -78.15 M Cost of revenue 14.12 M15.32 M21.5 M22.1 M30.7 M 89.62 M Other cost of goods sold 300 K1.1 M500 K300 K4.2 M 6.1 M Depreciation & amortization (cash flow) 442 K442 K402 K374 K— —